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ABSTRACT: The locus coeruleus (LC) is a small noradrenergic nucleus located in the midbrain that 
releases the neurotransmitter norepinephrine to diverse brain regions. Through release of 
norepinephrine, the LC plays a central role in modulating numerous physiological functions including 
attention, arousal, and mood and behavior. Although the LC projects to many brain region, there is limited 
information about the organization and the afferent projections to the LC that modulates its activity. The 
goal of this study was to characterize the anatomical projections between LC and cortical areas using a 
variety of different experimental techniques, including survival brain surgery, stereotaxic injections of 
fluorescent dyes, trans-cardiac perfusion, and immunohistochemistry. To determine cortical projections 
from different brain regions to the locus coeruleus, we injected the retrograde fluorescent tracer Fast 
Blue into the LC. Immunohistochemistry using dopamine-b-hydoxylase antibody allowed for detection of 
norepinephrine neurons and their extensive projections. The results from the experiment after 
microscopic imaging of the histology slices do not reveal a direct projection from the visual cortex to the 
locus coeruleus.
Introduction 
The words on this paper will have an impact on 
your attention. If you are interested in the words 
spurred across this page, your brain remains alert 
and attentive. Yet, if you’re being forced to find out 
new information and learn about the locus 
coeruleus, your brain will be overwhelmed and 
stressed because it is preparing itself for the 
information that it will engulf. Despite the ongoing 
battle we deal with everyday, we need to 
appreciate that our brain is constantly staying 
vigilant as it processes the variety of stimuli from 
our environment.  
The brain’s alertness is regulated by one of it’s 
smallest nuclei, the locus coeruleus (LC). The LC 
releases the neurotransmitter norepinephrine to 
diverse brain regions and modulates our 
physiological functions, hence our attention, 
arousal, and mood and behavior [1]. This small 
nucleus is made up of a population of cells packed 
together that send extensive projections to 
different brain regions. LC modulates activity of 
these brain regions through its release of 
norepinephrine. To determine the output 
projections of the LC, immunolabeling techniques 
using dopamine-b-hydroxylase (Dbh) antibody 
allows for detection of norepinephrine neurons 
and their extensive projections. Dopamine-b-
hydroxylase is an enzyme that converts 
dopamine to norepinephrine and is exclusively 
expressed in LC neurons [2]. Nearly all the brain 
regions from the medulla to the olfactory bulb 
contain Dbh-positive axons [3]. The use of Dbh 
antibody provides information about the 
organization of these efferent projections. To 
identify neurons sending afferent projections to a 
target brain area, researchers use retrograde 
tracing [4]. Combined together, Dbh-staining and 
retrograde tracing allow identification of specific 
LC projections into a target area. 
Recent studies have suggested that the 
pupil diameter can be influenced by LC activity 
independent from ambient light intensity. The 
change in pupil diameter is thought to be related 
to the activity of norepinephrine (NE)-releasing 
neurons in the brain stem nucleus LC [5]. 
Preliminary results (not shown) from the Chubykin 
lab suggested that the pupil diameter change 
(independently from the luminance change) 
correlated with neuronal activity in the primary 
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NeuroStar Robot Stereotaxic Solutions – the equipment used to perform the survival brain 
surgery (craniotomy) and the injection of the retrograde tracer Fast Blue fluorescent dye 
visual cortex, which may be a behavioral readout 
of visual perception. However, it was not clear 
whether visual stimuli themselves can cause NE 
release and consequently changes in the pupil 
diameter. We hypothesized that there may be a 
direct projection from the visual cortex to LC.   
The goal of our study was to test the 
hypothesis that there is a direct projection from 
the visual cortex to the LC. Our data showed that 
visual stimuli induced pupil size change, which 
could be the result of direct modulation of LC from 
visual cortex in early visual processing. 
Alternatively, pupil size change can be indirectly 
regulated from the higher level cortical areas such 
as the prefrontal cortex (PFC). To test our primary 
hypothesis, the LC was targeted by a retrograde 
tracer fast-blue dye to label all projections onto LC 
from other brain areas. However, locating the LC 
for the dye injection remained challenging due to 
its small size and lack of distinctive anatomical 
landmarks. Therefore, in order to verify correct 
targeting of the LC, immunohistochemistry (IHC) 
technique was performed using dopamine-b-
hydroxylase (Dbh) antibody.  
Methods 
Adult female C57/BL6 mice were utilized 
in this experiment. All animal procedures were 
approved by the Purdue Animal Care and Use 
Committee (PACUC). Injection glass pipettes 
were pulled from borosilicate glass capillaries 
(World Precision Instruments: Kwik-Fill) with a 
pipette puller (Sutter Instruments, P-97). The tip 
of the glass pipette was cut to achieve a diameter 
of approximately 1mm with scissors and back-
filled with Mineral Oil. Dye loading and injection 
were actuated using microinjection system 
(Drummond) controlled by MicroSyringe Pump 
Controller (World Precision Instrument). 
All animals were deeply anesthetized with 
isoflurane during the surgical procedures, 
confirmed by breathing frequency and 
responsiveness to toe pinching. Anesthesia was 
induced with 5% isoflurane and maintained with 
2% isoflurane while body temperature was 
maintained at 37 degrees Celsius with heating 
pad (ATC World Precision Instruments). 
Stereotaxic craniotomy and injection were 
conducted using a robotic surgical system 
(NeuroStar Robot Stereotaxic Solutions). Surgical 
area was disinfected with 70% ethanol before 
removing the skin and 3% hydrogen peroxide 
before the craniotomy. Injection speed was 
maintained at 50nL per minute. The craniotomy 
was covered with Kwik-Cast sealant (World 
Precision Instruments) and the skull was sealed 
with dental cement (Ortho-Jet, Lang Dental). To 
locate the locus coeruleus (LC), the following 
coordinates were used; -1.2mm for 
anterior/posterior, -0.8mm for medial/lateral, and 





After survival brain surgery, the mouse 
was allowed five days for recovery and retrograde 
labeling. Trans-cardiac perfusion with the use of 
ketamine (100mg per kg body weight) and 
xylazine (16mg per kg body weight) cocktail as 
anesthesia, was done following the recovery. The 
brain was sliced for immunohistochemistry (IHC) 
on a vibration microtome (Vibratome 1000plus) at 
100µm thickness. Free floating sections IHC was 
performed in 24-well culture plate. Primary sheep 
anti-dopamine-b-hydroxylase (DBH) antibody 
(Abcam) and secondary donkey anti-sheep DBH 
antibody – Alexa Fluor 488 (Abcam) were used 
for the IHC. Both the primary and secondary DBH 
antibodies were diluted to 1:1000 of their original 
concentration with phosphate buffered solution 
(PBS). Brain slices were blocked with blocking 
buffer consisting of 0.1% TritonX100, 5% (w/w) 
bovine serum-albumin (BSA, Sigma), in PBS (Dot 
Scientific). Primary incubation was at 4°C 
overnight and secondary incubation was at room 
temperature for one hour. Three times rinsing with 
PBS (10minutes each) was done before and after 
each incubation step. Brain slices were mounted 
onto glass slides with glycerol based anti-fading 
medium with 4-Nitrophenyl β-D-glucopyranoside 
(NPG, Sigma) and sealed with clear nail polish. 
All IHC slides were examined under inverted 










Fast Blue fluorescent dye is a retrograde neuronal tracer and is 
passive diffusive; it is effectively transported over long distances 
and it can be used to develop a neuronal pathway. Fast Blue dye 
excitation wavelength is around 365nm and its emission 
wavelength is around 420nm.   
Diagram Model Credit: Fast Blue model 




The image on the left is an image from Allen Mouse Brain Atlas 
depicting the circled LC region from a sagittal view. The image 
on the right is a sagittal view displaying the hypothesis of this 
study; to test if there is a direct projection from primary visual 
cortex to LC. 
 
Fig. 4 
Areas of Interest: LC (Fig 4A-D) and Primary Visual Cortex (V1) (Fig. 
4E) 
Fig. A and B are sagittal views of the LC and Fig. C and D are coronal 







Co-localization of Injection Tract 
Images above are pseudo colored. Fig. 5A-D are coronal views of the 
brain and Fig. 5E-H are sagittal views of the brain 
Fig. 5A and C have two red circle to indicate LC appearing on the left 
hemisphere (5A) and then the right hemisphere (5C) two slices later. 
The green color images were to show the DBH antibody staining and 
the red color images were to show the fast-blue dye injection tract. 
 
 
A B C D 












From prior studies and existing protocols, 
retrograde tracers have been used to map 
neuronal projections, thus retrograde tracer Fast 
Blue fluorescent dye was used in this experiment 
to determine projections from different brain 
regions to the LC. Fig.2 is a model diagram 
created to show how the retrograde tracer Fast 
Blue fluorescent dye works. The dye was bright 
enough to be seen in the brain slices under an 
epifluorescent microscope (this can also be seen 









Fig.3 are images depicting the hypothesis of the 
project: to determine whether there are cortical 
projections from different brain regions such as 
the primary visual cortex to the LC. The fast-blue 
dye was successfully injected into the LC in 




















Fig.4 are images showing the areas of interests. 
These are the areas that were targeted in the 
experiment. Fig.4A-D are different views 
illustrating the LC and Fig.4E is a coronal view of 













Fig.5 images are the main findings of this 
experiment. Fig.5A-D are coronal views of the 
brain and Fig.5E-H are sagittal views of the 
brain. It was found that the dye appeared too 
strong in both the brains (coronal and sagittal 
views). The dye had covered up any visible trace 
of the dopamine-b-hydroxylase (DBH) antibody 
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as seen in the images above. In other words, the 
DBH antibody was not seen in any of the brain 
slices from those images. The coronal brain 
sections in Fig.5A-D were found to have two dots 
that appeared individually, first in the left 
hemisphere and then the right hemisphere but 
not together in both hemispheres within the 
same slice. Other findings that are not shown 
showed no projections from the primary visual 
cortex to the LC. Although some areas of the 
visual cortex, other than V1, may have fast blue 
labeling, the result was not conclusive and 
further investigation is needed.  
Discussion 
In order to determine if the fast-blue dye was 
successfully injected into the LC, DBH antibody 
staining was used. DBH is expressed in NE 
neurons, thus DBH immunostaining labels the 
LC area. If the fast-blue dye was injected into the 
LC, then DBH antibody staining (green 
fluorescence) and fast-blue should co-localize. 
Because this is the first time such experiment is 
conducted in the Chubykin lab, we attempted to 
optimize the conditions including the 
concentration of the primary and secondary DBH 
antibody. The concentration of DBH used for 
both the primary and the secondary antibody as 
stated above in the methods, were 1:1000. A 
concentration higher than the suggested 1:2000 
was used because 1:2000 antibody was not 
sufficient under our histology condition (100µm 
thick slices cut with Vibratome). Furthermore, 
with our current epifluorescent microscope filter 
setting, the fast-blue dye fluorescent signal 
significantly bled into the green channel, 
interfering with DBH antibody staining. It was not 
possible to determine where LC was relative to 
the injection site. Figure 5F and H are sagittal 
slices depicting the fast-blue dye injection. From 
Figure 4B, the sagittal image from Allen Mouse 
Brain Atlas indicated that the LC is located 
between the cerebellum and the cerebrum. In 
comparison to Figure 5F and H, the injection 
seemed like it was in the correct area based on 
morphology, but was not confirmed due to the 
stated reasons.  
Example images of successful IHC highlighting 
the LC region can be found in other studies, for 
example on Allen Mouse Brain Atlas 
(http://www.brain-map.org/). When comparing 
the example images to the images taken in 
Figure 5A-D, the LC was hardly visible or not 
visible at all. Firstly, in Figure 5A and C, the two 
images fail to show the entire brain slice. In other 
words, the bottom half of the brain slices were 
missing, thus making it difficult to make an 
accurate comparison with the example images of 
the Allen Mouse Brain Atlas. Nevertheless, in 
Figure 5A and C, the two images illustrate two 
dots that are circled in red. These two dots could 
potentially be the LC. However, in an ideal image 
of IHC highlighting the LC region, these dots 
should have appeared together within the same 
slice. From the images in Figure 5A and C, the 
dots do not appear together. Instead, the dot first 
appears in the left hemisphere and then making 
an appearance in the right hemisphere. This 
indicated that the brain may have been sliced 
unevenly.  
The green and red images as stated in the 
caption above are pseudo colored. The green 
images were taken to see if the DBH antibody 
had stained the slices. The red images were 
used to show the fast-blue dye injection. 
Nonetheless, when the two images, green and 
red were compared with each other, the results 
were inconclusive. It was difficult to distinguish 
between the DBH antibody and the fast-blue 
dye. This was due to the fact that the fast-blue 
dye overlapped (bled into) with the GFP (green) 
channel. In other words, the fast-blue dye’s 
emission wavelength (peaking at 420nm) 
overlapped the GFP channel’s filter bandwidth, 
thus making it hard to distinguish between the 
two or to detect the antibody due to the strong 
dye. In Figure 5A-D and E-H, the microscopic 
images also demonstrate other areas along the 
injection tract and the edges of the slice that 
were highlighted with the DBH antibody. This 
was most likely due to diffusion of the dye along 
the injection damage after retracting the pipette. 
It could also be due to the mistake of fast blue 
injection targeting another nucleus other than the 
LC, the signal of which also bled into the GFP 
channel.  
Conclusion 
The results shown here indicated that the 
injection of fast-blue dye into the locus coeruleus 
(LC) and the dopamine-b-hydroxylase (DBH) 
antibody staining do not show projections from 
the visual cortex. The main issues of the process 
were determining whether the fast-blue dye was 
  Wang, Wu, and Chubykin 
 
5 
successfully injected into the LC and performing 
brain slicing for immunohistochemistry (IHC). If 
the injection of the fast-blue dye was not 
reaching the LC, then the tracing result would be 
from other nuclei nearby which is not informative 
for our purpose. 
Future Direction 
Future work should be focused on using 
secondary antibodies coupled to an Alexa Fluor 
546 nm fluorophore to separate fast-blue 
fluorescent signal and DBH antibody staining. 
We can also inject retrograde virus such as 
rabies virus carrying Cre-dependent flurorescent 
protein gene (eg. GFP) into a transgenic mouse 
TH-CRE (or DBH-CRE) to enable more specific 
LC targeting for retrograde tracing.  
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